Telerehabilitation for Rural Patients with Metastatic Prostate Cancer

This study is looking at how a special program called Telerehabilitation Intervention (TR) can help men with metastatic prostate cancer (cancer that has spread to other parts of the body) who live in rural areas. Many men with prostate cancer, especially those receiving androgen deprivation therapy (ADT, a hormone treatment), experience side effects that affect their quality of life. While exercise can help, it's often hard for rural patients to access rehabilitation programs. This study will provide a computer-guided rehabilitation program through a touchscreen tablet for home use. Researchers want to see if this program improves your quality of life, measured by a survey called FACT-P, over a 6-month period. The study plans to enroll 74 men.

Study design
This is an interventional study, meaning participants will receive a specific intervention. It plans to enroll 74 men.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your quality of life will be measured for up to 6 months from the start of the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07032584

Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer

Recruiting
NAAges 21+InterventionalSupportive care
University of Utah
~74 participants
Updated 2025-08-01 on ClinicalTrials.gov
What's tested:Telerehabilitation Intervention

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Functional Assessment of Cancer Therapy-Prostate (FACT-P)
Measured over up to 6 months from baseline
Prostate Cancer
Metastatic Prostate Cancer
Androgen Deprivation Therapy
1 sites across 1 states
Utah1
  • Manish Kohli, MD · PRINCIPAL_INVESTIGATOR · University of Utah

Opens a ready-to-send draft in your own email app — review before sending.

  • Functional Assessment of Cancer Therapy-Prostate (FACT-P)up to 6 months from baseline

    To assess disease-specific quality of life (QOL) in prostate cancer patients. FACT-P is a 5-point Likert scale from "0 Not at all" to "4 Very much". The FACT-P is a 39-item questionnaire with a minimum score of 0 and a maximum score of 156. Lower scores indicate worse QOL, and higher scores indicate better QOL. This outcome measure will report mean FACT-P total score.